Member Info for Wilson63

No it's not bank holiday changed to Friday for VE Day

Greggreen I wouldn't have found that but the sign of a quality poster to me is gggg21 he posted same at 1229 yet just rolled with your post fair play, and I'm not dissing you whatsoever as I'm saying I wouldn't have found it.

Richken it's not false news he's just not aware of this version of the test.

On the assay table there are x thousand schedules that PrimerDesign scientist have identified, what is a schedule? Pleassssse

Did I miss this earlier teg on twitter

https://mobile.twitter.com/goundoulel/status/1256512426826256386/photo/1

BIOskunk nothing is impossible but with huge revenues coming in I see no reason they will require funds in the next xx years.

UP I enjoyed the film kevin tks

I've been reading the Rns again and there are three definitions of adjunct I prefer this version and feel it's appropriate

adjective
connected or added to something.
"other adjunct therapies include immunotherapy"
Shows to me Dr Alistair Smith knows the score and is quite happy all the excellent testing methods have a place at the table.

In both as is probably obvious, however anything to move the narrative from where it is now.

Frankly I was being facetious:)

P.s I think we have revenues.

My wife says I can dance to northern soul as I'm always out of time!! Hell shes right.

So I didn't think I'd get through six hundred and odd posts so I'll read the last two pages nah.

I initially thought it was same affirmer different company but it's not using spare hospital equipment to increase testing brilliant, needs all the companies producing at max capacity, let's get this virus under control. No crying from me (boohoo:)

Capt hindsight get that on the radio bril:)

Tomvisual Tks for your reply. It was more a question of "as well as" I'm happy with company updates it's my head that's trying to process it/them.

Sgd27 Tks for the lead going back in time I note the following.

Changes in the collaboration financial arrangements include:
Pharmaxis has significantly increased its share of any partnering deal for the LOXL2 program in fibrotic diseases to over 80%.
Synairgen has retained a reduced but fixed percentage share of all future partnering revenues.
Pharmaxis has assumed full funding responsibility for the ongoing collaboration program.
Pharmaxis will make a cash payment to Synairgen of £5 million (approximately A$9m).

So Synairgen have in effect a "free ride" and have a 17%?? stake.

Tomvisual Tks for your response last night regarding 960,000 dPCR per week and not per month. Therefore my thick question if we are going up to 8 million are we outsourcing 4mil(yougene etc) and are we continuing to make the standard pcr? I can't stack this in my head sorry.

Are results not week commencing the 11th? In case they need any wiggle room!

Bravo again gggg21 I'd imagine the French would understandably be upset if anything dropped tomorrow,...surely not.

Hi all finally had some money to buy in here today got waylaid at work came on at 1230 ish fomo'd and bought on the spike ouch anyway question on loxl2
Pi news report

https://www.proactiveinvestors.co.uk/companies/news/212781/synairgens-loxl2-fibrosis-drugs-ready-for-phase-ii-trials-212781.html
Is from 2017 seems a long time until the phase one test in oz

http://www.pharmaxis.com.au/product-pipeline/amine-oxidase-platform/loxloxl2/

Any reason or is that a normal time scale.

Avacta